Alginates in therapy for gastroesophageal reflux disease].

V G Avdeev

Terapevticheskiĭ arkhiv 2015

filter terms:

all
compound
phenotype
FDA drugs
show more »
show less «

This article presents evidence of the prevalence of gastroesophageal reflux disease (GERD) and highlights its main treatment options. Among its medications, particular emphasis is laid on alginates and their main mechanisms of action are described. There is information on the efficacy of alginates, including the alginate-antacid Gaviscon Double Action, in treating GERD. Recommendations for how to administer these drugs are given.